Huge Sales Quarter Positions Gilead To Be Significant M&A Player
This article was originally published in The Pink Sheet Daily
Executive Summary
Hepatitis C franchise adds nearly $3 billion to Gilead’s cash coffers, leaving the firm to ponder bigger ambitions.